SPEAKERS
Nadezda Abramova, Safety Strategy Lead, Merck Healthcare KGaA
Ajibade Adesina, Director, PV Process Excellence and Learning Strategy, Bristol-Myers Squibb
Ana Sofia Afonso, Director, Pharmacoepidemiology, Global Patient Safety, Eli Lilly
Vivek Ahuja, Senior Vice President, Global Delivery Excellence, Strategy & Growth, PV, Quality & Regulatory Service Lines, EVERSANA
Donia Al-Bastaky, Head of Drug Safety, Ministry of Health, Kuwait
Sarah Al-Musaed, Regulatory Affairs and Drug Safety Manager (LRP-PV), Grünenthal Denmark ApS
Ibrahim Altamawy, Medical Affairs & Compliance Regional Head (MENA), SAJA Pharmaceuticals
Gabrielle Amselem, Director, Patient Safety Excellence, AstraZeneca & Alexion
Paridhi Anand, Director, PV Operations, Standard and Training in Case Processing, Moderna Therapeutics
Kate Anteyi, Director, Global Safety Physician, Moderna Therapeutics
Wasim Anwar, Vice President & Deputy QPPV, Novo Nordisk A/S
Julia Appelskog, EU QPPV, Global Vaccine Safety, Novavax
Simon Ashworth, Head of Pharmacovigilance and Medical Safety, Ono Pharmaceutical Co., Ltd
Mina G Awad, Pharmacovigilance Manager and QPPV, Middle East., Kyowa Kirin International
Tea Babic, Director, Head of PV Audits and Inspections, Deputy Head PV Compliance, Teva Pharmaceuticals
Amina Baljic, Head of PV Ops & PV Excellence, Grunenthal
Leesha Balramsingh-Harry, Safety Data Acquisition Lead, Roche
Alexandru Barbarosie, EU/UK QPPV, Global Safety Lead, Amryt Pharma
Erika Barbarosie, Associate Director, Compliance, Gilead Sciences
Iain Barnden, PV Partner Manager for Digital Innovation, Pharmalex
Judy Barretto, Global Process Owner, Signal Management Director, Roche
Linda Bech, Associate Director, Head of Patient Safety Nordics, Gilead Sciences
Michael Becker, International PV, Global Head, PV Hubs, ROCHE
Lisa Benaise, Vice President, Head of PV, Calliditas
Begum Benli Peker, Director, Head of Patient Safety Netherlands & Hub Lead, Bristol Myers Squibb
Majken Berghuis, Director, Pharmacovigilance, International Operations, Novo Nordisk
Gemma Berry Jones, Associate Director, GVP Quality, Kyowa Kirin
Delphine Bertram, Head of Safety Vigilance, EMEA, EU QPPV, Santen
Fabrice Besle, Director, PV Database & Analytic Reporting, Ipsen
Fatima Bhayat, Vice President, Head of Global Patient Safety and Chief Safety Officer, Amgen Inc
Raj Bhogal, Senior Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals
Kapil Bhutada, Senior Director, Quality and Compliance, Inozyme Pharma
Saikat Biswas, Global Head of Medical devices & Pharmaceutical services, Wipro
Klaus Bitsch-Jensen, Director, Head of QPPV Office, EU QPPV, ALK
Laura Paola Boga, Head of Global Pharmacovigilance, UK & EU QPPV, Dompé farmaceutici SpA
Ellen Bonagua, Executive Director, Drug Safety, Insmed Incorporated
Emma Boulton, Director, Safety Operations, Mundipharma
Ronald Boumans, EU Medical Devices Expert
Michael Braun-Boghos, Senior Director, Safety Strategy, Oracle Health Sciences
Emma-Jane Brookes, Co-Founder, Partner, Truliant Consulting
Jeff Brown, Chief Scientific Officer, TriNetX
Siva Kumar Buddha, Global Pharmacovigilance Physician, Senior Manager, Teva Pharmaceuticals
Christine Buggle, Senior Director, TransPerfect
Sean Burke, Senior Director, Regional Lead, International Pharmacovigilance, MSD
Gloria Bustos, Senior Director, Head of Pharmacovigilance, EMEA & APAC / Global Patient Safety, Baxter Healthcare
Azira Cajic, Head of Division for Pharmacovigilance and Materiovigilance ALMBiH, Agency for Medicinal Product and Medical Devices BiH
Mattia Calissano, Head of Pharmacovigilance, Orchard Therapeutics
Isabella Caramuta, Deputy QPPV, Shionogi BV
Pilar Carrero, Vice President, Global Safety, LEO Pharma
Patrick Caubel, Chief Safety Officer, Pfizer
Akhilesh Chamediya, Director, Senior Medical Expert Drug Safety, EU QPPV, AiCuris Anti-infective Cures AG
Mijal Chavda, Senior Director, Global Head of GxP Inspections & GVP Quality, Kyowa Kirin International
Minyar Chelly Kahloun, QPPV Director, ProductLife Group
David Chonzi, Global Head of PVE, Instil Bio
Irina Maria Ciubotaru, Head of Pharmacovigilance and Drug Safety, ITM Isotope Technologies Munich SE
Mircea Ciuca, Independent PV Expert
Jan Cleerbout, Deputy EU QPPV, QPPV Office, Johnson & Johnson
Marco Colombati, PV Operations Manager, ITALFARMACO S.P.A.
Lynne Comiskey, PV Regions Hub Coordination Lead, Sanofi
Galina Cordero, Head of Pharmacovigilance Department, QPPV, JSC Farmak
Marlo Corrao, Quality Director, Pharmacovigilance Excellence, GSK
Carolyn Cranfield, Director, Global Process Owner, PV Excellence, Global Safety, GSK
Joan D’souza, Independent PV Expert
Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics
Maria Dahlin, Director, Global Pharmacovigilance & Patient Safety, Sobi (Swedish Orphan Biovitrum)
Margherita D'Antuono, EU-UK QPPV, Piramal Critical Care
Karolina Danysz, Associate Director, PV Affiliate Relations Liason, EUCAN, Takeda
Adeline Darchy, Director, Clinical Research, Voisin Consulting Life Sciences
Richard Dart, Executive Director, Rocky Mountain Poison & Drug Center
Jay Dave, Technical Director, Pharmacovigilance, COD research
Abiola David, Senior Director, Global Process Owner, ICSR Management, PV Operations, GSK
Jolanda De Bruijne, Senior Director, Head of PV Compliance, Teva Pharmaceuticals
Fabio De Gregorio, Vice President, Head Of Drug Safety Europe, Shionogi BV
Peter De Veene, QPPV, Incyte Biosciences
Wivina De Waele, Senior Director, Safety Lead Europe, Global Patient Safety, Alexion – AstraZeneca Rare Disease
Antoinette Defaux, Associate Director, Pharmacovigilance, UBC
Melanie Demarke, Director, Global Process Owner, PV Excellence, Global Safety, GSK
Sameen Desai, Executive Director, Head of Worldwide Patient Safety and Risk Management IT, Bristol-Myers Squibb
Sunita Dhar, Executive Medical Group Director, Clinical Safety, Genentech
Daniela Di Cosmo, Senior Safety Advisor, Global Safety, Ferring Pharmaceuticals
Robert Di Giovanni, Global Patient Safety Lead, Novartis
Juergen Dietrich, Senior Lead Data Scientist, Pharmacovigilance, Bayer AG
Steve Dingman, Vice President, Head of Pharmacovigilance, ImmunoGen Inc
Hanneke Dominicus, Senior Manager, Benefit Risk, ProPharma Group Inc.
Markus Drumm, Head of Global Patient Safety Regions, Merck Healthcare KGaA
Marjan Dzeparoski, RA and PV Manager, Bionika Pharmaceuticals
Phillip Eichorn, Global Head of Drug Safety, Amryt
James Eldridge, Director, Pharmacovigilance North America, Y-mAbs
Mahalakshmi Elluri, Global Safety Director, Indivior Pharmaceuticals
Ellen Ravn Englev, Senior Director, SO Processes & PV Technology, Safety Operations, Global Safety, Novo Nordisk
Joann Evangelista, Director, Head of PV Operations, US Patient Safety, Genentech
Natalie Farrar, Director, Safety and Pharmacovigilance, ViiV Healthcare
Lilliam Fernandes, Director, Clincial Safety and Pharmacovigilance, Adaptimmune LLC
Kevin Fetterman, Exec Director, Client Engagement, Orbit By Feith Systems
Veronica Fjellstrom, Head, Global Patient Safety & Medical Information, EU & UK QPPV, Karo Pharma
Franciane Flament, Senior Director, GPS Regional Oversight Team Head, Ipsen
Marie Flanagan, Director, Offering Management, IQVIA Vigilance Detect
Garry Flounders, Global Pharmacovigilance Operations Lead, Biosimilars, Biogen
Suzanne Foncin, Senior Director, Head of Safety Analysis and Writing, UCB
Antonella Fretta, Senior Director, Aggregate Reporting Team Lead, Pfizer
Tsambika Fuchs, Team Lead PV Intelligence and Performance Management, Merck Healthcare KGaA
Giovanni Furlan, Worldwide Safety Site Lead & Safety Risk Lead Director, Pfizer
Stewart Geary, Global Safety Officer, Eisai
Lalit Gehani, Practice Lead, Reporting & Analytics, Ultragenic
Serban Ghiorghiu, Chief Safety Officer, AstraZeneca
Clara Goncalves, Head QPPV And Alliance Office, Grunenthal
Daniela Gramaglia, Medical Device Vigilance Manager, Chiesi Farmaceutici SpA
Lucy Green, QPPV Activity Manager, ProductLife Group
Ilaria Grisoni, Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV, Jazz Pharmaceuticals
Katarzyna Gruchala, Director, PV Operations Case Processing, Moderna
Uwe Gudat, Chief Medical Officer, Aretaeus sàrl
Sibel Guerler, Head of Innovation, Partnerships and Process Optimisation, WorldWide Patient Safety, Bristol Myers Squibb
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics
Diane Halle, Senior Manager, Pharmacovigilance Quality Assurance, Alnylam Pharmaceuticals
Lucy Hampshire, Associate Vice President, Head, Medicines Quality Organisation International, Eli Lilly And Company
Linda Härmark, Deputy Director, Netherlands Pharmacovigilance Centre Lareb
Balwant Heer, Vice President, Global Head of Drug Safety, Viatris
Fabian Heisig, SVP, Head Global Drug Safety & Qualified Person for Pharmacovigilance, Grunenthal
Rainer Heissing, Executive Director, Deputy EU/UK QPPV, Gilead Sciences
Janni Hermansen, Head, Global Safety Surveillance, Biologics & Devices, LEO Pharma
Philipp Hofmann, Director, Pharmacovigilance and Global QPPV, Navitas Life Sciences
Martin Holm-Petersen, CEO, Insife
Noelle Humphrey, Vice President of Quality, Primevigilance
Tuula Ikonen, Head of Pharmacovigilance, E.O.R.T.C.
Inge Jeding-Jansen, Senior Director, Head of Global Pharmacovigilance, ALK
Gemma Jimenez Sese, Patient Safety Director, Almirall
Henk Johan Streefkerk, CEO & Medical Director, Amarna Therapeutics Bv
Conny Johansson, Alliance Management Lead, Roche
Philip Jones, Senior Director, Disease Area Cluster Lead, Inflammation & Immunology, Pfizer
Juhaeri Juhaeri, VP & Head, Epidemiology and Benefit-Risk, Sanofi
Caitlin Keel, Director, Global Head of Case Management & Standards, Global Product Safety and Pharmacovigilance, United Therapeutics
Ranjana Khanna, Global Director, GVP, QA, Clinical and Medical Quality, BeiGene GmbH
Elian Khazneh, Head of GPS, Benefit Risk Strategy and Management, Global Patient Safety, Merck Healthcare KGaA
Meredith Kiley, Senior PV Operations Manager, US Patient Safety, Genentech
Christina Kim, Senior Director, Vault Safety, Veeva Systems
Mohammed Ali Kotal, Global Head, Medical Safety, Sandoz International GmbH
Smruti Kothari, Associate Director, PV QA, Jazz Pharmaceuticals
Monika Kowalska, Director, PV Operations ICSR Quality, Moderna
Marcin Kruk, Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East, Pfizer
Sergiy Kryvych, Senior Drug Safety Officer & Medical Advisor, Deputy Local Pharmacovigilance Responsible Person, Pfizer
Amit Kubavat, Global Program Safety Lead, Sandoz International GmbH
Leith Kwaan, QPPV, National Bioproducts Institute NPC
Wally Landsberg, VP, Global Head Medical Safety, Kyowa Kirin, Inc.
Maud Le Petitcorps, Associate Director Safety Oversight, Johnson & Johnson
Jill Leake, Director, Head of Clinical Safety Operations, Merck Healthcare KGaA
Stella Lee, Asia-Pacific Drug Safety Unit, Coordinating Manager, Menarini Group
Jost Leemhuis, Safety Science Partner, ROCHE
Claudia Lehmann, Vice President, Head Global Patient Safety & Pharmacovigilance Operations, Boehringer Ingelheim International
Camille Lenoir, Safety Scientist, UBC
Petra Lerner-Hiller, PV Quality and QPPV Relations Lead, Deputy QPPV, Merck
David Lilienfeld, Vice President, Drug Safety and Pharmacovigilance, Elevar Therapeutics
Luiz Lima, Vice President, Global Patient Safety, Therapeutic Area Lead, Neuroscience, Ipsen
Maria Maddalena Lino, Safety Risk Lead Director, COVID Vaccine, Pfizer
Anna Liptak Askne, Director, ICSR Post-marketing, AstraZeneca
Emanuel Lohrmann, Director, PV Therapeutic Area Lead, Cardio Renal, Otsuka Pharmaceuticals
Karsten Lollike, Corporate Vice President, QPPV, Novo Nordisk
Anja-Helena Loos, Director, Biostatistics Oncology, MERCK
Kausik Maiti, Senior Medical Director, Parexel International
Valentina Mancini, Senior Director, Pharmacovigilance, QPPV, Shionogi & TransCelerate
Monika Manske, Lead Quality Management and Deputy EEA QPPV, Viatris
Marcin Marciniak, Senior Director, Global Safety and PV Expert WHC, Gedeon Richter Switzerland
Jennifer Markey, Chief Sales & Marketing Officer, Insife
Jessica Mårlind Würtele, Director, Patient Safety Excellence, AstraZeneca
Hayley Marsh, Senior Vigilance Scientist, Voisin Consulting Life Sciences
Robert Massouh, Head, Risk Management and Benefit-Risk Evaluation, GSK
Jorgen Matz, Head of Global Pharmacovigilance & Clinical Quality, EU QPPV, Insud Pharma
Wumi McDowall, Director, Pharmacovigilance, Medical & Regulatory QA, Seqirus
Nkululeko Mdladla, Clinical Safety Manager, ViiV Healthcare
Olga Menang, Director, Drug Safety and Pharmacovigilance, Fresenius Kabi
Jordi Mestres, CSO & Founder, Chemotargets
Natasa Mihajlovic, Managing Director, NostraPharma Ltd
Amira Modi, Global Head, SRQ GTM Strategy, Marketing and Enablement, IQVIA
Deanna Montes de Oca, Senior Director PV Operations -Case Management, Moderna Therapeutics
Marianne Mounir, Senior Global Auditor, Bayer
Jeremie Dedessus Le Moutier, Head of Global PV Excellence, Global Safety, GSK
Sutirtha Mukhopadhyay, Senior Patient Safety Physician, Boehringer Ingelheim
Santanu Mukhopadhyay, Head, Medical Safety, VecturaFertin Pharma
Roger Mutter, Deputy QPPV, Galapagos GMBH
Kieran O'Donnell, Independent PV Expert
Dagmara Okla, Senior Director, Head of Global Safety, Clinical Development & Medical Affairs Quality, Excellence & Governance, EU QPPV, Haleon
Attila Olah, Head Global Patient Safety, EU/UK-QPPV, Gedeon Richter PLC
Bartosz Olas, Principal Safety Data Manager, Global Pharmacovigilance Case Management, MSD Polska
Thomas Organ, Safety Science Director, Neuroscience, Global Patient Safety, Ipsen
Devi Padmanaban, Executive Director, Drug Safety, Neurocrine Biosciences
Will Pajak, Senior Business Process Leader, International Patient Safety, Roche
Bruce Palsulich, Vice President, Safety, Oracle Life Sciences
Shaloo Pandhi, Senior Vice President, Global Head, Patient Safety, Sandoz
Olga Panek-Białkowska, Associate Director, Global Pharmacovigilance Case Management, MSD Polska
George Patrinos, Professor, Department of Pharmacy & Adjunct Professor, Department of Genetics and Genomics, University of Patras & United Arab Emirates University
Anna Pelnivekich, Director, Head, Project Safety Reports, Merck
Mark Perrott, Founder, Managing Partner, Axian Consulting Ltd.
Emmanuelle Pinès, Head of Safety Policy & Process Oversight, QPPV Office, Janssen
Mary Lynne Van Poelgeest-Pomfret, President, World Federation For Incontinent Patients
John Poustie, EMEA Pharmacovigilance Director, UK QPPV, Haleon
Humaira Qureshi, President, Qinecsa Solutions
Sophie Radicke, Head of GPvP and Senior Pharmacovigilance Inspector, MHRA
Samah Ragab, Director, Regulatory Affairs & PV, Middle East, Organon
Anne Raison, Head of Quality and Medical Compliance Management, ROCHE
Meenakshi Ramachandran, Manager, Drug Safety, Molecular Partners AG
Kavita Ramji, Safety Officer, Pfizer
Nibedita Rath, Scientific Director, Open Source Pharma Foundation
Franziska Rathjens, Head of Business Process Management & PV Tools, Deputy QPPV, B Braun
Sandra Reda, Quality Assurance Specialist & Deputy QPPV, RAY-CRO
Jane Reed, Director, NLP, Safety & Regulatory, IQVIA
Maria Jose Reneses, Director, Deputy EU QPPV and Head of PSMF, Takeda
Pav Rishiraj, Director, Head of Patient Safety & PV Expert Chair, Ipsen & ABPI
Nathan Rivers, Senior Manager, Medical Safety, Jazz Pharmaceuticals
Renato Rjavec, Product Director, ArisGlobal LLC
Hans-Jörg Römming, Executive Director, Head of GPS Operations, Merck
Hadir Rostom, President, ISoP Egypt Chapter
Inder Sachdeva, Global Delivery Leader, Cognizant
Kishore Saha, Chief Specialist, Lundbeck
Balaji Sainath Malla, Head of Pharmacovigilance, QPPV- EU & UK, Dr. Reddy's Laboratories Inc
Myriam Salem, Pharmacovigilance Manager, Health Canada
Dnyaneshwar Sanap, EU & UK QPPV, Head, Regional PV and Global Compliance Training, Glenmark Pharmaceuticals
Teresa Saragoça, Director, Regulatory Affairs & Technical Manager, Italfarmaco
Gemma Sayers, Director, Pharmacovigilance Quality Management Lead, Regeneron Pharmaceuticals
Kay Saywell, Global Head of Pharmacovigilance, Dr Reddy's Laboratories (EU) Ltd
Rudi Scheerlinck, Safety Strategy Lead, Merck Healthcare Oncology
Santiago Schiaffino, Medical Director, Senior Patient Safety Physician, AstraZeneca
Reinhold Schilling, Head of Global Pharmacovigilance, EU QPPV, Wörwag Pharma GmbH & Co. KG
Vipin Sethi, Head Of Global Pharmacovigilance And Medical Affairs, Cadila Pharmaceuticals
Nikesh Shah, Vice President, Global Head, Drug Safety & PV, Indegene
Mason Shih, Vice President, Safety Science, BioMarin Pharmaceutical Inc.
Vedaant Shourie, SME, PV Business & Systems Implementations, Pinnaxis
Francoise Sillan, Vice President, Global Patient Safety, EU & UK QPPV, Ipsen
Elizabeth Smalley, Director, Product Management Data and Analytics, ArisGlobal LLC
Howard Snow, Vice President, Head of Pharmacovigilance, Sobi (Swedish Orphan Biovitrum)
Marianne Soergel, Drug Safety Lead, Molecular Partners AG
John Solomon, Head of Pharmacovigilance, UK & Ireland, Sanofi
Ira Solomon, Chief Safety Officer, Innovation, Johnson & Johnson
Sanjeev Srivastav, Director, PV Signal, RxLogix
Galina Stamenova, Senior Safety Manager, Excelya
Jens-Ulrich Stegmann, Senior Vice President, Head Clinical Safety and Pharmacovigilance, EU QPPV, GSK
Ada Stelmakiene, Head of Pharmacovigilance, Insuvia
Darren Stewart, Chief Experience Officer, Competency Accelerator, F. Hoffmann-La Roche
Mette Stie Kallesøe, Head of Pharmacovigilance, QPPV, Hansa Biopharma
Branka Stojanovic, Country Safety Lead, Serbia, QPPV, Pfizer
Milos Stojkovic, Safety Process Director, ROCHE
Ariane Stollenwerk, Head of Central Europe & Asian Int. Markets, International PhV,, UCB Pharma
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Marko Strott, Associate Director, Partnership Management, Global Patient Safety, Merck
Marina Suvakov, Global Head Product, Safety Surveillance, Philip Morris International
Amar Swaroop, Director, Global Lead, Customer Engagement Programmes, Viatris
Jutta Syha, Independent PV Expert
Stephanie Tcherny-Lessenot, Global Head of Benefit-Risk Evaluation, Sanofi
Maria Tello, Senior Medical Director, Patient Safety & PV Lead, Strategy and Innovation, Horizon
Karin Thelen, Head of Drug Safety, Cardior Pharmaceuticals
Ricarda Tiemeyer, Head of Pharmacovigilance, DACH Region, Biogen
Anna Karin Traff, Director, ICSR Lead, AstraZeneca
Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency
Marco Tuccori, Pharmacovigilance Manager, Coordinator & Co-Chair, University Hospital of Pisa, Tuscan Regional Centre of Pharmacovigilance & ISoP Scientific Board
Alina Tudor, Senior Director, Pharmacovigilance, Kyowa Kirin
Veronica Urdaneta, Senior Director, Global Safety Physician, Moderna
Raphael Van Eemeren, Senior Director, EU/UK QPPV, Global Patient Safety,, Amgen
Eva Van Engelen, Director, Global Patient Safety, Gilead Sciences
Lionel Van Holle, Founder, OpenSourcePV
Bert Van Leeuwen, Deputy QPPV, Astellas Pharma Europe BV
Sarah Vaughan, Head of Vigilance Development, MHRA
Ram Vempati, Former Head of Pharmacovigilance, Arcellx Inc
Deepa Venkataraman, Vice President, Drug Safety and Pharmacovigilance, Corcept Therapeutics
Venkat Venkataramanan, PV Domain Lead, Cognizant
Tommaso Venturi, Corporate Risk Assessment Specialist, ITALFARMACO S.P.A.
Sumit Verma, President, Clinical Safety and PV, Soterius, Inc.
Jin Vermaat, Vice President and Head of PV Affiliate Relations, Takeda
Michael von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars, Biogen
Sanjay Vyas, Executive Vice President, Safety & Logistics and Country Head of India, Parexel
Nicola Wallis, Executive Director, PV Innovation, UK QPPV, BeiGene Germany GmbH
Aman Wasan, Chief Commercial Officer, ArisGlobal LLC
Heinz Weidenthaler, Vaccine Pharmacovigilance Expert, Bavarian Nordic
James Whitehead, Senior Director, Devices and Digital Safety, Astra Zeneca
Mark Widdowson, Manager, Digital Insights and Innovation, Bristol Myers Squibb
Emma Wiman, Director, Regulatory Compliance & Quality, EMENA, accord healthcare
Beena Wood, Senior Vice President, Safety & Medical Affairs Product Management, ArisGlobal LLC
Dimitris Zampatis, Global Program Safety Lead, Global Patient Safety, Sandoz
Iva Zgombic Rukavina, Medical Affairs and Pharmacovigilance Senior Associate, Belupo Inc
Monika Zych, Director, Pharmacovigilance ECEMEA, Baxter
Get Involved At
World Drug Safety Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events